Análisis de minimización de costes del tratamiento del dolor en la artrosis de rodilla o cadera con paracetamol o inhibidores de la COX-2 (rofecoxib)

Lizán Tudela, L; Magaz Marqués, S; Varela Moreno, C; Riesgo Bucher, Y.
Aten. prim. (Barc., Ed. impr.) ; 34(10): 534-540, dic. 2004. ilus, tab
Artigo em Espanhol | IBECS (Espanha) | ID: ibc-135969

Documentos relacionados

  1. Actions following adverse drug events - how do these influence uptake and utilisation of newer and/or similar medications?
  2. A systematic review and trial sequential analysis of intravenous vs. oral peri-operative paracetamol.
  3. No need to tax the sick: clinical guidelines for rofecoxib as an alternative effective method to the copayment policy in the advent of increasing pharmaceutical expenditures.
  4. COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective.
  5. Comparative Analysis of Inpatient Costs for Obstetrics and Gynecology Surgery Patients Treated With IV Acetaminophen and IV Opioids Versus IV Opioid-only Analgesia for Postoperative Pain.
  6. Assessing the cost-effectiveness of COX-2 specific inhibitors for arthritis in the Veterans Health Administration.
  7. [Analysis of cost-minimization treatment with paracetamol or COX-2 inhibitors (rofecoxib) for pain from arthrosis of the knee or hip].
  8. Fund Black scientists.
  9. A cluster randomized trial to measure the impact on nonsteroidal anti-inflammatory drug and proton pump inhibitor prescribing in Italy of distributing cost-free paracetamol to osteoarthritic patients.
  10. Management of ED under the "severe distress" criteria in the NHS: a real-life study.